News, reviews and podcasts from annual scientific meetings and symposiums around the world.
An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined…
The Phase 1/2 LINKER-MM1 trial of linvoseltamab in patients with relapsed/refractory (R/R) multiple myeloma (MM)…
In a study presented today at the American Association for Cancer Research (AACR) Annual Meeting…
A video designed to educate Black men about prostate cancer resulted in 97% of surveyed participants…
A combination of the KRASG12C inhibitor adagrasib and the anti-epidermal growth factor receptor (EGFR) antibody…
The first-in-class PARP1-selective inhibitor saruparib demonstrated encouraging early efficacy and a favourable safety profile in…
Testing for tumour DNA in the blood can successfully identify advanced bladder cancer patients who…
A simple urine test can more than halve the number of cystoscopies necessary to follow…
A simple blood test every five years is sufficient to screen low-risk men for prostate…
A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center (USA) investigators suggests that…